Foreigners own 5.13% of pharmaceutical stocks worth of KRW 4.2 trillion
Although the foreigner-owned stock portion reaches averagely 20% in the Korea stock market, it was observed the amount of foreigner-owned pharmaceutical stocks accounted barely for 5%.
That is, it means the domestic pharmaceutical company is not able to attract interests of foreigners as the tar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.